~~<i id='1415AF6B7E'><strike id='1415AF6B7E'><tt id='1415AF6B7E'><pre id='1415AF6B7E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：leisure time 2025-08-12 11:29:08 - browse：28955

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Paying for Covid pills will soon shift to insurers

hotspot

knowledge

Wikipedia

entertainment

explore

leisure time

AtableladenwithPPEandmedicalsuppliessuchassplitsponges,disposablebloodpressurecuffs,andgloves.DavidJ

WSS

Fentanyl is making it harder to start addiction treatment

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Fentanyl is making it harder to start addiction treatment

Eli Lilly to pay $200M for Beam’s stake in gene

FDA has safety concerns on CRISPR

Why Sanofi got shellacked over its spinoff

hotspot

leisure time

hotspot

Drug repurposing or repositioning? The language matters

FDA poised to publish guidelines for clinical trial diversity

The high cost of giving birth even with insurance

Meta's Zuckerberg and Chan on track to put $50 billion into science

DIEP, the 'gold standard' of breast reconstruction, is under threat

Questions and answers about ramping up H5N1 bird flu vaccine

The high cost of giving birth even with insurance

CDC recommends rationing of RSV shot due to shortages

Jerome Adams on the need for new antivirals for Covid

Paying for Covid pills will soon shift to insurers

knowledge

Readout Newsletter: What happened with Sarepta's Duchenne data

Meta's Zuckerberg and Chan on track to put $50 billion into science

Traditional Chinese medicine benefits explored in new JAMA study

CDC recommends rationing of RSV shot due to shortages

H5N1 bird flu outbreak: Second human case reported, in Michigan

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Wikipedia

entertainment

explore

leisure time